Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema.

Keyphrases

• Parapneumonic Empyema 100%
• Parapneumonic Effusion 100%
• Antifibrinolytic Therapy 100%
• Complicated Parapneumonic Effusion 100%
• Effusion 60%
• Pneumonia 40%
• Exudative 40%
• Pleural Empyema 40%
• Clot 20%
• Recombinant 20%
• Pulmonary Infection 20%
• Systemic Antibiotics 20%
• Pleural Effusion 20%
• Fibrinolytic Therapy 20%
• Low pH 20%
• Lactate Dehydrogenase 20%
• Pleural Cavity 20%
• Bacterial Cells 20%
• DNase 20%
• Cell Metabolism 20%
• Single Patient 20%
• Multiloculated 20%
• Excess Mortality 20%
• Mismanagement 20%
• Chest Tube Drainage 20%
• Fibrinous 20%
• Intrapleural 20%
• White Cell 20%
• Pleural Space 20%
• Tube Surgery 20%
• Empyema 20%
• Fluid Sequestration 20%
• Intrapleural Fibrinolytic 20%
• Fibrinolytic Agents 20%

Medicine and Dentistry

• Fibrinolytic Therapy 100%
• Effusion 100%
• Empyema 100%
• Pleural Cavity 22%
• Patient with Pneumonia 22%
• Pleura Effusion 11%
• Leukocyte 11%
• Lactate Dehydrogenase 11%
• Bacterial Cell 11%
• Cell Metabolism 11%
• Chest Tube 11%
• Lung Infection 11%
• Deoxyribonuclease 11%
• Thrombolytic Drug 11%
• Intrapleural Drug Administration 11%
• Antibiotics 11%